Our ref. : L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiry of 28 May 2018 enquiring about the number
of non-refouleme...
Our reference: L/M (39) in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email dated 23 August 2018 enquiring about
non-refoulement claims si...
Our ref. : L/M (6) in ImmD RALS1/6-20/3/C
Dear Ms Li,
Thank you for your email dated 20 June 2019 seeking access to information
relating t...
Our ref. : IL/00317473/22, L/M (85) in ImmD RALS1/6-20/3/C
Dear Moazam,
We refer to your application for access to information of 3 June 20...
本處檔號: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
I write further to our interim reply of 28 March 2018 with regard to your
email dated 9 March...
Our reference : L/M (37) in ImmD RALOS/6-20/3/C
Dear Ms Li,
I refer to your email dated 9 August 2018 requesting for information
relating to n...
Our ref. : IL/00279092/19 and L/M in ImmD RALOS/6-20/3/C
Dear Mr Santikarn,
I refer to your email dated 15 April 2019 concerning the number of
Fi...
Our ref. : L/M (3) in ImmD RALS1/6-20/3/C
Dear Mr Andrew Meehan,
Thank you for your email dated 6 June 2019 seeking access to information...
本處檔號: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiry dated 31 July 2017. Please note that
ImmD does not...
Our Reference: L/M (7) in ImmD ORS/6-5/2 (C) Pt.3
Dear Surabhi Chopra,
I refer to your application for access to information submitted on 2...
Our ref. : IL/00025904/22, L/M (2) in ImmD ORS/6-5/2 (C) Pt.4
Dear H. Y. Fung,
I refer to your application for access to information submitted...
本處檔號: L/M (35) in ImmD RALOS/6-20/3/C
Dear Mr Edmunds,
Thank you for your enquiry dated 4 June 2017.
There is no procedure to "re...
本處檔號: L/M in ImmD RALOS/6-20/3/C
Dear Mr. Edmunds,
Thank you for your email enquiry dated 18 September 2017.
Please be informed...
Our ref. : IL/00375755/19 and L/M (2) in ImmD RALS1/6-20/3/C
Dear Mr Santikarn,
I refer to your application for access to information on 28...
Our ref.: L/M (19) in ImmD RALS1/6-20/3/C
Dear Ms Anderson,
Thank you for your enquiry on 11 February 2020.
Please be informed that t...
本處檔號: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiry dated 6 October 2017. Regarding the
matters raised therein,...
To: [1][FOI #258 email]
Subject: Freedom of Information request – Permission to work for
non-refoulement claimants and refugees
Our ref. : L/M...
Our ref. : IL/00050116/20 and L/M (16) in ImmD RALS1/6-20/3/C
Dear Ms Anderson,
We refer to your application for access to information of...
Our ref.: L/M (46) in ImmD RALS1/6-20/3/C
Dear Mr Edmunds,
We refer to your application for access to information of 12 November 2020
relating...
Our ref.: L/M (67) in ImmD RALS1/6-20/3/C
Dear Ms Anderson,
We refer to your application for access to information of 21 July 2021
relating to sta...
Our ref.: L/M (66) in ImmD RALS1/6-20/3/C
Dear Ms Alam,
We refer to your application for access to information of 20 July 2021
relating to...
Our ref.: L/M (79) in ImmD RALS1/6-20/3/C
Dear Roy Njuabe,
We refer to your application for access to information of 13 January 2022
relat...
Our Ref.: L/M (5) in ImmD AP 6-5/1/C
Dear Ms CHOPRA,
Our department has received your application for access to information on
02.05.2021....
Andy Chui:
(本署編號:DO EC 2342/22)
就你於2022年12月14日的電郵查詢,衞生署現回覆如下:
立法會財務委員會已批准撥款設立接種2019冠狀病毒病疫苗後出現的異常事件保障基
金。保障基金是為了接種新冠疫苗後出現未能預見的嚴重異常事件(包括死亡和嚴重
傷害)...
傳真 : 2882 8149
電話 : 2629 0428
本函檔號 : L/M (4a) to OMB/G/16/03 III
主旨 :索取資料要求–主動調查及主動調查審研列表
st...